Visera LLC Announced the Launch of MyVital ID
New Consumer-Focused Biometric Wellness App Using Transdermal Optical Imaging (TOI) and AI-Driven Wellness Data is Now Available Visera, LLC today announced the official launch of...
Category : Biomarkers
OncoHost Publishes Landmark JPBA Proteomics Study
OncoHost, a technology company transforming precision oncology through proteomics and AI, today announced the publication of a new study in the Journal of Pharmaceutical and Biomedical...
FYR Bio Appoints Barbara K. Zehentner, MBA, PhD, HCLD (ABB), as COO
Veteran laboratory operations leader brings deep expertise scaling high-complexity CLIA/CAP environments and multiomic platforms to support FYR’s EV-Omics growth across neuroscience and oncology FYR Bio (“FYR”),...
Precision for Medicine Expands Globally with Singapore Office Opening
Singapore Office Expands APAC Presence to Seven Locations, Delivering Enhanced Local Expertise and Global Scale Precision for Medicine (Precision), a global leader in biomarker-driven clinical...
Agentis Longevity Announces Acquisition of BioDesign
Agentis Longevity, an industry leader in best-in-class longevity healthcare and medicine, today announced the acquisition of BioDesign, a premier, Florida based longevity healthcare company, specializing...
Ginkgo’s GPT-5 Lab Cuts Protein Synthesis Costs by 40%
Ginkgo Bioworks (NYSE:Â DNA) today announced it has demonstrated, in collaboration with OpenAI, an AI system that autonomously designed, executed, and learned from biological experiments with...
Cumulus Neuroscience Appoints Ricardo Sáinz Fuertes, MD as New Board Chair
Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, announced today that...
Withings Redefines Preventive Health with Body Scan 2
After inventing the world’s first connected scale in 2009, Withings is redefining preventive health once again with Body Scan 2, the most advanced home longevity station...
Circular Genomics Adds Leading Alzheimer’s Experts to SAB
Michael Weiner, MD and Timothy Hohman, PhD, bring decades of experience in neurological diseases with a focus on Alzheimer’s disease Circular Genomics, a leader in...
Circular Genomics Announces Closure of $15 Million Series A Financing
Financing accelerates clinical validation and commercial readiness, as circular RNAs emerge as a new category of brain-derived blood biomarkers with best-in-class performance Circular Genomics, Inc.,...